CSEG3060 · Research Methodology in Computer Science
Exclusive, non-exclusive and sole licences · the anatomy of a licence agreement · royalty structures · and the mechanisms that move an invention to market
A licence is a personal privilege, not a transfer of title. The licensee gets exactly what the agreement enumerates — and nothing else.
Unit VI · Lecture 2 of 4 · 60 minutes · CO3 · B.Tech (CSE) Semester V
Dr. Mohsin Furkh Dar · School of Computer Science, UPES
→ / Space next · ← back · O overview · N speaker notes · F full screen
Learning outcomes · CO3
Define patent licensing and distinguish it from assignment
Compare exclusive, non-exclusive and sole licences across exclusivity, royalty and risk
Identify the principal clauses of a licence agreement and explain why the grant clause is the most litigated
Compute royalties under lump-sum, running, per-unit, milestone and minimum-floor structures
Differentiate the eight mechanisms by which patented technology moves from laboratory to market
Apply TRL assessment, market sizing and the three valuation methods to a commercialisation decision
Foundations
Patents are treated as movable property and may be licensed, assigned or mortgaged under:
Indian Patents Act, 1970 — Section 68 onwards
US Patent Act — 35 U.S.C. §261
European Patent Convention — Article 73
Software-related inventions, communication protocols and hardware designs are typically patented but rarely commercialised through in-house production alone. The value is in adoption across an ecosystem, which is exactly what licensing enables and assignment does not.
Types · 1 of 4
University spin-out commercialisation · pharmaceutical licensing of a blockbuster molecule where one licensee manufactures globally · semiconductor foundries licensing process patents from a fabless design house.
In computing: common in specialised embedded systems, AI accelerators and proprietary database engines.
Shelving. An exclusive licensee who lacks incentive to commercialise broadly can simply sit on the invention — which is why performance milestones and minimum annual royalties exist, and why reversion clauses matter to a university licensor.
Types · 2 of 4
Standard-essential patents licensed through patent pools — MPEG-LA, Sisvel · codecs, image formats and communication protocols — H.264/AVC, H.265/HEVC, 4G LTE · open specifications where multiple implementations must coexist.
Non-exclusive licensing is the dominant model for standard-essential patents precisely because interoperability requires that everyone can implement the standard. The FRAND commitment — fair, reasonable and non-discriminatory terms — is what a patent holder gives in exchange for having its technology written into the standard.
Example: IBM historically generated over $1 billion annually from patent licensing by offering non-exclusive licences across its semiconductor and software portfolio.
Types · 3 of 4
A hybrid. The licensor grants the licensee the right to practise, retains its own right to practise, but undertakes not to grant any further licences to third parties.
Only two parties may practise the patent: the licensor and the sole licensee. The licensee cannot exclude the licensor.
Joint research arrangements where one party retains background rights and grants a sole licence over foreground developments.
Manufacturing arrangements where the patent owner also produces competing goods and is unwilling to exit the market.
| Dimension | Exclusive | Sole | Non-exclusive |
|---|---|---|---|
| Number of licensees | One | One | Unlimited |
| Licensor may practise | No | Yes | Yes |
| Licensor may license further | No | No | Yes |
| Royalty magnitude | Highest | Intermediate | Lowest |
| Risk to licensor | Highest | Intermediate | Lowest |
Types · 4 of 4
Two or more parties exchange licences to their respective patents. Widespread in high technology where firms hold dense, overlapping portfolios — the smartphone “peace” agreements are the canonical example.
Imposed by the State in defined public-interest circumstances — non-working in the territory, semiconductor technology under specific national laws, or a government-use notification.
The COVID-19 vaccine landscape brought these powers to international attention.
A single licence bundling patents owned by different entities. Typical for standards-implementing technologies, and the market’s answer to negotiating with fifty patentees separately.
A licence granted by an existing licensee to a third party. It requires explicit authorisation in the primary licence — it is never implied.
A modern smartphone reads on tens of thousands of patents held by dozens of parties. Negotiating bilaterally with each is impossible, and each demanding a percentage of the handset price produces royalty stacking — a combined burden exceeding what the product can bear. The pool, the aggregate royalty cap and the SSPPU concept on slide 11 are all market responses to that arithmetic.
The agreement · 1 of 2
Establishes the parties, the background and intent, and a definitions subsection.
Definitions must be unambiguous and exhaustive — particularly “Licensed Product”, “Licensed Process”, “Territory”, “Field of Use”, “Net Sales”, “Affiliate” and “Effective Date”.
“Net Sales” deserves particular care: it is the base on which every running royalty is computed.
It must specify:
The grant clause is the most heavily litigated provision in any licence. And under customary principles of contract interpretation, ambiguity in the scope of the grant almost always favours the licensee.
If you are the licensor, every word you leave vague is a word a court will read against you.
The agreement · 2 of 2
Minimum sales or production volumes by set dates · commercially reasonable efforts · minimum annual royalties · periodic progress reports. Failure typically triggers reversion of rights.
Who owns improvements: licensor ownership (licensee assigns) · licensee ownership with a licence-back · joint ownership, common in university–industry work.
Periodic royalty reports showing units sold, net revenue, royalties due and currency. The licensor retains audit rights, usually annual, to verify accuracy.
Warranty of title — the licensor owns the patent. Warranty of non-infringement of third-party rights — often heavily contested and frequently disclaimed.
Duration, renewal, termination for breach or insolvency, and post-termination rights — including sell-off periods for inventory already manufactured.
Protects the know-how transferred alongside the patent, which is frequently worth more than the patent itself and is not published.
Choice of law, forum, and whether disputes go to arbitration — the norm in cross-border technology agreements.
Royalties · 1 of 3
A single fixed payment at the outset or on a milestone.
+ Certainty; no ongoing accounting
− Does not scale with success; overpayment risk if the product fails
Used in university licensing, one-time software access fees
A fixed percentage of net sales per period.
+ Scales with revenue; aligns incentives
− Requires monitoring and audit
Typical range in software and ICT: 1–12% of net sales
A fixed amount per unit sold — USD 0.50 per device, INR 1.00 per chip.
+ Simple; easy to verify
− Misses value from price inflation or premium positioning
Used in codec licensing, semiconductor IP
Linked to defined events — regulatory approval, first commercial sale, sales thresholds, development stages.
Requires clear, objective milestones, or the clause becomes the dispute.
A floor the licensee pays regardless of actual sales.
Characteristic of exclusive licences, and the principal defence against under-utilisation.
Most contemporary agreements are hybrid: a small upfront lump sum, plus milestone payments, plus a running royalty, plus a minimum annual floor.
Royalties · 2 of 3
R total royalty owed · S net sales of the licensed product in the period · r royalty rate as a decimal, e.g. 0.05 for five percent.
Where a minimum floor applies, the period royalty becomes Rt = max( r · St , Rmin )
When the licensed product incorporates many technologies, on what do you charge the percentage? The whole handset, or the chip?
The answer developed by the market and the courts is the smallest saleable patent-practising unit (SSPPU) — which limits the licensor’s claim to the contribution of its own technology alone.
Where many licensors each demand a percentage of the total product price, the combined burden can exceed commercially sustainable levels — and the product becomes unmakeable.
Three market responses: patent pools, aggregate royalty caps, and the SSPPU base.
Royalties · 3 of 3
A firm licenses a patented compression engine from a university. Non-exclusive, 4% of net sales. It sells 250,000 units at a net price of INR 800.
R = 250,000 × 800 × 0.04 = INR 8,000,000A chipset maker licenses error-correction technology at INR 1.20 per unit, with a minimum annual royalty of INR 5,000,000. It produces 3,500,000 units.
Computed = 3,500,000 × 1.20 = 4,200,000 Minimum = 5,000,000 Due (higher) = INR 5,000,000A robotics start-up licenses an obstacle-detection patent: INR 4,000,000 upfront; INR 2,000,000 on first commercial sale; 3% running royalty. Year 1: milestone triggered, 50,000 units at INR 25,000.
Milestone = 2,000,000 Running = 50,000 × 25,000 × 0.03 = 37,500,000 Year 1 total = INR 39,500,000Negotiation
Royalties are treated as royalty income in the country of receipt and are subject to withholding tax at source. International licensing is affected by Double Taxation Avoidance Agreements. Whether a payment is classified as “royalty” or “business income” materially changes the tax and is frequently contested in audits — so the characterisation belongs in the agreement, not in hindsight.
Part 2 begins
The lifecycle of an invention does not end at grant. The patent is merely the legal instrument that lets the owner control how the invention enters the market. The actual movement from laboratory to productive commercial use is technology transfer.
Technology transfer is the silent engine behind nearly every product you use: the video codec in your streaming service, the instruction set in your processor, the cryptographic primitives securing your transactions, the machine-learning libraries powering your applications.
Most originated in research environments and reached the public through deliberate transfer mechanisms — not by accident.
TT
Conveying technical knowledge, skills, processes or materials between organisations for development or commercialisation
TTA
The binding contract defining the terms of that transfer
Know-how
Unpatented, often tacit technical knowledge supporting practical application
TRL
A 9-point scale of technology maturity, from basic research to proven deployment
Technology transfer · 1 of 2
The owner retains title and grants permission to make, use, sell or import, in exchange for consideration. Exclusive, sole, non-exclusive or cross — as analysed in the first half of this lecture.
IBM historically earned over $1 billion a year from non-exclusive licensing of its semiconductor and software portfolio.
Ownership transfers permanently; the original owner retains nothing. Under Section 69, assignments must be registered with the Controller to be valid against third parties — an unregistered assignment is void against a later assignee for consideration.
Common in acquisitions of startups, inheritance and restructuring, and university-to-startup transfers where the startup buys the patent outright.
Two or more parties pool resources. Used where the technology requires complementary assets, where neither party can commercialise alone, or where risk-sharing is wanted.
Intel and Micron co-developed 3D XPoint memory through the IM Flash Technologies joint venture, with cross-licensed patents enabling the partnership.
A new company founded to commercialise a specific technology, usually out of a university lab. The founding institution typically holds equity, licenses the relevant patents to the spin-off, and provides initial funding and incubation.
Google grew out of Stanford’s PageRank research; subsequent patents shaped its commercialisation.
Technology transfer · 2 of 2
An external sponsor funds specific research in exchange for defined rights to the resulting IP. Terms — typically negotiated by the TTO — cover ownership of foreground IP, license-back rights to the institution, and publication rights.
The publication-rights clause is the one academics must read: a sponsor can lawfully delay your paper.
Govern the transfer of tangible materials or restricted datasets under defined conditions. Relevant in biotechnology and, increasingly, in software research where the “material” is a proprietary dataset or model. Frequently accompany patent licences.
Franchising transfers a complete business model — patents, trademarks and know-how together. Technical assistance agreements provide consulting and engineering support, usually combined with a licence.
Open-source licensing operates on copyright, but many projects depend on patents for technical implementation. Patent pools aggregate complementary patents for collective licensing.
Standard-essential patents for 4G LTE, 5G NR and Wi-Fi 6 are commercialised through FRAND pools. The MPEG LA pool licenses the patents essential to H.264, used across the streaming industry.
The agreement
Transferor — often a TTO, corporation or individual inventor — and transferee. For university patents the transferor is the institution, with the inventor named in a recital.
Precise identification of the patents, know-how and materials transferred.
Scope, exclusivity, field of use, territory — as in any licence.
Upfront payment · milestones · running royalties, commonly 2–8% in software · minimum annual royalties · sublicensing revenue share.
Who owns inventions the licensee makes during the term that rely on the licensed technology: sole licensee ownership, joint ownership, or mandatory licence-back.
Whether sublicensing is permitted — common in distribution-heavy industries, heavily restricted in exclusive university licences. Performance milestones with reversion on failure.
Who has the right and the duty to sue infringers, who bears the cost, and how recoveries are split.
Warranties and indemnities · term and post-termination rights · confidentiality · dispute resolution · compliance with law, including export control.
Commercialisation · 1 of 3
1 Basic principles observed
2 Technology concept formulated
3 Experimental proof of concept
4 Validated in the laboratory
5 Validated in a relevant environment
6 Demonstrated in a relevant environment
7 System prototype demonstration
8 System complete and qualified
9 System proven in an operational environment
Commercialisation typically begins in earnest at TRL 4–6 — when the invention is mature enough to interest a licensee, but before the institution has sunk the capital that industry is better placed to provide.
Below TRL 4 there is nothing to demonstrate; above TRL 6 the institution has usually spent money it will struggle to recover through royalties alone.
Commercialisation · 2 of 3
(a) Cost approach — the cost to develop a substitute. Useful for early-stage technology where revenue is uncertain.
V_cost = C_R&D + C_patent + C_legal(b) Market approach — comparable transactions in the same technology class. Difficult in software because of rapid obsolescence.
(c) Income approach — the most rigorous: project future cash flows attributable to the patent and discount to present value.
V_income = Σ FCF_t / (1+WACC)^t − V_tangibleCommercialisation · 3 of 3
Out-licensing to an established firm — low capital requirement, faster market entry. The default for a university with no manufacturing capacity.
Spin-off formation — higher potential return, but higher risk and capital requirement. Chosen when no incumbent will take the technology at TRL 4.
Cross-licensing with a partner — useful when the technologies are interdependent and neither party can ship without the other.
Patent assertion — aggressive, litigation-driven monetisation, characteristic of non-practising entities. Effective, and reputationally costly for an academic institution.
Standards contribution — embedding the patented technology into an industry standard, generating FRAND royalty streams at scale. The highest-leverage route in ICT, and the slowest.
Consolidation
A university licenses your project’s algorithm at 5% of net sales with a INR 200,000 minimum annual royalty. Year 1 sales: 3,000 units at INR 1,200. Compute the royalty due, then decide whether the licence should be exclusive and justify it in two sentences.
1–12% running royalty range in software and ICT · 2–8% typical in a software TTA · TRL 4–6 commercialisation window · 25% Rule for profit split · s.69 registration of assignments
Next — Lecture 3: Patent Information, Databases and the Administration of the Patent System: patent literature, IPC and CPC classification, the major databases, search strategy, and recent reforms.